Skip to top bar
Skip to header
Skip to content
Skip to footer
CS
>
Publications
>
Publication Records - Search
Publication Records - Search
Advanced search
Repository
Selected publication/outcome records
Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: a cause for immune impairment (2012)
Myc 9aaTAD activation domain binds to mediator of transcription with superior high affinity (2024)
CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vdelta1+ gamma-delta T Cells (2013)
Vdelta1 gamma-delta T cell-mediated killing of myeloma cells: a new candidate for immunotherapy (2013)
Interactions of plasmacytoid dendritic cells with myeloma plasma cells and gamma/delta T cells in MGUS and multiple myeloma patients (2013)
Reduced thymic output in elite athletes (2014)
ROLE OF CYTOMEGALOVIRUS SEROPOSITIVITY ON AGEING OF THE INNATE IMMUNE SYSTEM OF GAMMA-DELTA T CELLS IN HEALTHY DONORS (2014)
Shared structural features of the 9aaTAD family in complex with CBP (2015)
Analýza expresie receptorov EphA1 a EphA2 u nádorových bunkových línií (2016)
Do human B-lymphocytes avoid aging until 60 years? (2016)
Buněčná analýza plasmacytoidních dendritických buněk u mnohočetného myelomu (2016)
Analysis of the EphA2 Receptor Expression on Malignant Plasma Cells and Plasmacytoid Dendritic Cells in MGUS and Multiple Myeloma Patients (2016)
Analysis of gamma-delta T cells and plasmacytoid dendritic cells in MGUS and Multiple Myeloma patients (2016)
Analysis of anti-tumour and anti-viral reactivities of human gamma-delta T cells (2016)
The 9aaTAD Transactivation Domains: From Gal4 to p53 (2016)
The 9aaTAD Is Exclusive Activation Domain in Gal4 (2017)
Nuclear hormone receptors: Ancient 9aaTAD and evolutionally gained NCoA activation pathways (2019)
The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases (2018)
The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with valines and intron reservoirs (2020)
Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable (2020)
Multidisciplinární přístup v léčbě gliomů - astrocytomy a oligodendrogliomy (2020)
Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma (2021)
The 9aaTAD Activation Domains in the Yamanaka Transcription Factors Oct4, Sox2, Myc, and Klf4 (2021)
Universal two-point interaction of mediator KIX with 9aaTAD activation domains (2021)
Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing (2021)
Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme (2021)
Gamma-delta T cells in Glioblastoma patients (2021)
Innate gamma-delta T cells in endometriosis (2020)
Gamma-delta T cells in Glioblastoma patients (2021)
Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme (2021)
Innate gamma-delta T cells in endometriosis (2020)
Investigations of gamma-delta T cells in patients with monoclonal gammopathy (2013)
Vdelta1 T cells represent a dominant gamma-delta T cell subset in patients with multiple myeloma (2014)
Turning up the heat on human gamma-delta T cells in malignant disease (2017)
Tumour-reactive gamma-delta T cells targeting the EphA2 receptor in B- cell CLL (2018)
Detekce myeloidních supresorových buněk v nádorovém mikroprostředí (2020)
Tumour reactive Gamma Delta T Cells in Haematology (2017)
Vybrané markery nádorových buněk jako terapeutické cíle B-buněčných malignit (2018)
Infiltration of Gamma-delta T cells into Glioblastoma Tumor (2021)
CMV-reactive Vdelta1 gd T cells are equally cytotoxic to CMV-specific ab T cells in HLA-A*02 healthy donors (2022)
Cryptic inhibitory regions nearby activation domains (2022)
Clozapine Reverses Dysfunction of Glutamatergic Neurons Derived From Clozapine-Responsive Schizophrenia Patients (2022)
Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients (2022)
Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia (2023)
Tumor infiltration of gamma-delta T cells in glioblastoma (2022)
Gamma-delta T cells in patients with endometriosis (2023)
The NFkB activation domain is 14-amino-acid-long variant of the 9aaTAD (2023)
Targeting undruggable oncoproteins c-Myc and N-Myc by the 9aaTADs (2023)
Blockade of PD-L1 and B7-H3 checkpoint inhibitor ligands in glioblastoma (2023)
Harnessing the EphA2 blockade in glioblastoma (2024)
Expression of the immune checkpoint inhibitors on gamma-delta T cells in chronic myeloid leukemia patients during TKI therapy (2024)
Gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia (2024)
Innate effector gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia (2024)
Human Vdelta1 T cells represent a dominant gamma-delta T cell subset in patients with multiple myeloma (2013)
Remove all the items
Operations on the selected outcomes
Export and print
List of selected records
Other applications
Publications
Information System
Skip to top barSkip to headerSkip to contentSkip to footer
